Guy W. Bemis

6.3k total citations · 1 hit paper
24 papers, 3.7k citations indexed

About

Guy W. Bemis is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Guy W. Bemis has authored 24 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Computational Theory and Mathematics. Recurrent topics in Guy W. Bemis's work include Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (7 papers) and Melanoma and MAPK Pathways (5 papers). Guy W. Bemis is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (7 papers) and Melanoma and MAPK Pathways (5 papers). Guy W. Bemis collaborates with scholars based in United States and India. Guy W. Bemis's co-authors include Mark A. Murcko, Ajay, Albert C. Pierce, Keith P. Wilson, Irwin D. Kuntz, Michael Su, Paul R. Caron, S. Pazhanisamy, Jonathan M. Moore and Jeffrey W. Peng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemical Journal.

In The Last Decade

Guy W. Bemis

24 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Properties of Known Drugs. 1. Molecular Frameworks

1996 1.7k citations Guy W. Bemis, Mark A. Murcko Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy W. Bemis United States	21	2.3k	1.9k	946	586	484	24	3.7k
Steven L. Dixon United States	27	2.3k 1.0×	2.1k 1.1×	972 1.0×	470 0.8×	468 1.0×	46	4.2k
Douglas B. Kitchen United States	24	2.5k 1.1×	1.7k 0.9×	900 1.0×	466 0.8×	351 0.7×	45	4.3k
A. Geoffrey Skillman United States	17	2.5k 1.1×	1.9k 1.0×	693 0.7×	614 1.0×	404 0.8×	26	3.8k
Ingo Muegge United States	31	2.8k 1.2×	2.3k 1.2×	1.1k 1.2×	592 1.0×	494 1.0×	61	4.7k
Darren V. S. Green United Kingdom	28	1.8k 0.8×	1.7k 0.9×	906 1.0×	400 0.7×	354 0.7×	58	3.8k
Paul S. Charifson United States	29	2.9k 1.2×	1.3k 0.7×	726 0.8×	463 0.8×	357 0.7×	55	4.0k
Michal Vieth United States	25	2.4k 1.1×	1.4k 0.7×	727 0.8×	439 0.7×	412 0.9×	41	3.7k
Jordi Mestres Spain	37	2.3k 1.0×	2.1k 1.1×	870 0.9×	475 0.8×	518 1.1×	139	4.5k
Gaia V. Paolini United Kingdom	8	2.2k 1.0×	2.1k 1.1×	703 0.7×	596 1.0×	444 0.9×	9	3.5k
Michael M. Hann United Kingdom	27	2.5k 1.1×	1.5k 0.8×	927 1.0×	309 0.5×	499 1.0×	44	3.7k

Countries citing papers authored by Guy W. Bemis

Since Specialization

Citations

This map shows the geographic impact of Guy W. Bemis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy W. Bemis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy W. Bemis more than expected).

Fields of papers citing papers by Guy W. Bemis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy W. Bemis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy W. Bemis. The network helps show where Guy W. Bemis may publish in the future.

Co-authorship network of co-authors of Guy W. Bemis

This figure shows the co-authorship network connecting the top 25 collaborators of Guy W. Bemis. A scholar is included among the top collaborators of Guy W. Bemis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy W. Bemis. Guy W. Bemis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Tiansheng, Guy W. Bemis, Brian L. Hanzelka, et al.. (2017). Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. ACS Medicinal Chemistry Letters. 8(12). 1224–1229. 40 indexed citations

Bandarage, Upul K., Brian Hare, Jonathan D. Parsons, et al.. (2009). 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5191–5194. 21 indexed citations

Pierce, Albert C., et al.. (2009). Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase. Bioorganic & Medicinal Chemistry Letters. 19(11). 3019–3022. 47 indexed citations

Cao, Jingrong, Huai Gao, Guy W. Bemis, et al.. (2009). Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(10). 2891–2895. 36 indexed citations

Farmer, Luc J., Guy W. Bemis, John E. Cochran, et al.. (2008). Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry Letters. 18(23). 6231–6235. 25 indexed citations

Aronov, Alex M., Christopher Baker, Guy W. Bemis, et al.. (2007). Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors. Journal of Medicinal Chemistry. 50(6). 1280–1287. 98 indexed citations

Haar, Ernst ter, W. Patrick Walters, S. Pazhanisamy, et al.. (2004). Kinase Chemogenomics: Targeting the Human Kinome for Target Validation and Drug Discovery. Mini-Reviews in Medicinal Chemistry. 4(3). 235–253. 24 indexed citations

Aronov, Alex M. & Guy W. Bemis. (2004). A minimalist approach to fragment‐based ligand design using common rings and linkers: Application to kinase inhibitors. Proteins Structure Function and Bioinformatics. 57(1). 36–50. 19 indexed citations

Pierce, Albert C., et al.. (2004). BREED: Generating Novel Inhibitors through Hybridization of Known Ligands. Application to CDK2, P38, and HIV Protease. Journal of Medicinal Chemistry. 47(11). 2768–2775. 128 indexed citations

10.

Pierce, Albert C., et al.. (2002). Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding. Proteins Structure Function and Bioinformatics. 49(4). 567–576. 184 indexed citations

11.

Salituro, Francesco G., Ursula A. Germann, Keith P. Wilson, et al.. (1999). Inhibitors ofp38 MAP Kinase: TherapeuticIntervention inCytokine-Mediated Diseases. Current Medicinal Chemistry. 6(9). 807–823. 71 indexed citations

12.

Fejzo, Jasna, Christopher A. Lepre, Jeffrey W. Peng, et al.. (1999). The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chemistry & Biology. 6(10). 755–769. 194 indexed citations

13.

Ajay, Guy W. Bemis, & Mark A. Murcko. (1999). Designing Libraries with CNS Activity. Journal of Medicinal Chemistry. 42(24). 4942–4951. 251 indexed citations

14.

Bemis, Guy W. & Mark A. Murcko. (1999). Properties of Known Drugs. 2. Side Chains. Journal of Medicinal Chemistry. 42(25). 5095–5099. 202 indexed citations

15.

Wilson, Keith P., Patricia G. McCaffrey, Kathy Hsiao, et al.. (1997). The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chemistry & Biology. 4(6). 423–431. 239 indexed citations

16.

McPhee, Fiona, Patricia Caldera, Guy W. Bemis, et al.. (1996). Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochemical Journal. 320(2). 681–686. 58 indexed citations

17.

Bemis, Guy W. & Irwin D. Kuntz. (1992). A fast and efficient method for 2D and 3D molecular shape description. Journal of Computer-Aided Molecular Design. 6(6). 607–628. 56 indexed citations

18.

Bemis, Guy W., et al.. (1992). A molecular dynamics study of the stability of chymotrypsin acyl enzymes. Journal of the American Chemical Society. 114(2). 570–578. 13 indexed citations

19.

Maryanoff, Bruce E., David F. McComsey, Harold R. Almond, et al.. (1986). Dramatic reversal of diastereoselectivity in an N-acyliminium ion cyclization leading to hexahydropyrrolo[2,1-a]isoquinolines. A case of competing steric interactions. The Journal of Organic Chemistry. 51(8). 1341–1346. 24 indexed citations

20.

Bemis, Guy W., et al.. (1984). 1,3,4,6-Tetramethyl-1,4-dihydro-1,2,4,5-tetrazine, C6H12N4. Acta Crystallographica Section C Crystal Structure Communications. 40(12). 2076–2078. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact